HBX-19818 - Deubiquitinase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第1頁(yè)
HBX-19818 - Deubiquitinase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第2頁(yè)
HBX-19818 - Deubiquitinase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第3頁(yè)
HBX-19818 - Deubiquitinase 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEHBX 19818Cat. No.: HY-17540CAS No.: 1426944-49-1分式: CHClNO分量: 421.96作靶點(diǎn): Deubiquitinase作通路: Cell Cycle/DNA Damage儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 3.5 mg/mL (8.29 mM; Need ult

2、rasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.3699 mL 11.8495 mL 23.6989 mL5 mM 0.4740 mL 2.3699 mL 4.7398 mL10 mM - - -請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 HBX 19818種泛素蛋特異性蛋酶 (USP7) 抑制劑,IC50 值為 28.1 M。IC50 & Target IC50: 28.1 M (USP7) 1體外研究HB

3、X 19818 is an inhibitor of USP7, with an IC50 of 28.1 M. HBX 19818 shows no effects on USP8, USP5,USP10, CYLD, UCH-L1, UCH-L3 or on SENP1, a SUMO protease, with IC50s of 200 M. HBX 19818selectively inhibits USP7 with IC50 of -6 M in in human cancer cells. In addition, HBX 19818 (1.5, 4, 12, 36,1/3 M

4、aster of Small Molecules 您邊的抑制劑師www.MedChemEor 100 M) inhibits USP7 deubiquitination of polyubiquitinated p53. HBX 19818 (30 M) also causessignificantly higher levels of Mdm2 polyubiquitinated forms in USP7-overproducing HEK293 cells than thosein DMSO-treated control cells. HBX 19818 inhibits HCT116

5、 proliferation in a dose-dependent manner, withan IC50 of -2 M 1.PROTOCOLKinase Assay 1 The ability of HBX 19818 and HBX 28,258 to inhibit a panel of deubiquitinating enzymes, including UCH-L3(13 pM), USP7 (100 pM), USP8 (1.36 nM), UCH-L1 (2.5 nM), USP5 (10 nM), USP20 (10 nM), and USP2(500 pM), is t

6、ested using the UbAMC substrate (300 nM). The potential effects of HBX 19818 and HBX28,258 are also tested on the enzymatic activities of SENP1 (80 pM), cathepsin-B (100 pM), and caspase-3(100 pM) using the SUMO1-AMC (750 nM), ZRR-AMC (3 M), and DEVD-AMC (250 nM) substrates,respectively. All enzymes

7、 are tested in USP7 reaction buffer (50 mM Tris-HCl pH 7.6, 0.5 mM EDTA, 5 mMDTT, 0.01% Triton X-100, and 0.05 mg/mL serum albumin), except for two enzymes, USP8 (same buffer butpH 8.8) and caspase-3 (100 mM HEPES pH 7.5, 10% sucrose, and 0.1% CHAPS). All enzymes are pre-incubated with DMSO or compo

8、unds (including HBX 19818) for 30 min at room temperature, and theenzymatic reaction is initiated by adding the substrate of interest. The reaction mixture is incubated at roomtemperature for 1 hr, and the reaction is stopped by adding acetic acid (100 mM). The reactions aremonitored using the PHERA

9、star 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 HCT116 cell proliferation is evaluated by incubating HCT116 cells for 30 min in culture medium containing 10M 5- bromo-2-deoxyuridine (BrdU), which is incorporated into the DNA of proli

10、ferating cells. Cells are thenharvested by trypsin treatment, collected by centrifugation, and the pellet is resuspended and incubated in70% ethanol for 30 min at 4C. After centrifugation and supernatant removal, DNA is denaturated byincubating it in 2 N HCl for 30 min at room temperature. The perce

11、ntage of BrdU-containing cells is thendetermined by flow cytometry, making it possible to quantify proliferating cells. Cell cycle is evaluated aftertreatment with HBX 19818 for 24 hr, followed by fixing detached cells and trypsinized cells in 70% ethanol for30 minutes at 4C. Cells are then incubate

12、d in PBS supplemented with 1% BSA, 0.5% Tween 20, 50 g/mLRNase A and 50 g/mL propidiumiodide for 30 minutes at 37C. Samples are analyzed on a FACSortfluorocytometer. The percentage of cells in the different phases of the cell cycle is calculated using Multicyclesoftware 1.MCE has not independently c

13、onfirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Cell Metab. 2019 May 7;29(5):1166-1181.e6. Nat Chem Biol. 2017 Dec;13(12):1207-1215. Nat Struct Mol Biol. 2016 Apr;23(4):270-7. Mol Cell Biol. 2015 Apr 1;35(7):1157-68. Dev Growth Differ. 2019 Jan 10.See more customer validations on HYPERLINK / www.MedChemE2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEREFERENCES1. Reverdy C, et al. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol. 2012 Apr 20;19(4):46

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論